Our Management
Anish Bhatnagar, MD
Chief Executive Officer

Dr. Anish Bhatnagar is a physician with over 16 years of experience in the medical device and biopharmaceutical industry. His experience spans development of biologics, drugs, drug-device combinations and diagnostic as well as therapeutic medical devices. He has extensive experience in the pharmaceutical industry in all aspects of drug and device development and has a track record of the approval of multiple products (CoSense, Bexxar and Serenz). Anish has implemented clinical trials in several therapeutic areas all over the world.  He has been the lead in regulatory interactions with several divisions at the FDA and international regulatory authorities (UK, France, Australia and Sweden).

Anish has been at Capnia since 2006 where he has been responsible for raising over $25 million in equity and non-dilutive financing. His prior experience includes working at Coulter and Titan Pharmaceuticals. He is the author of several peer-reviewed publications, abstracts and book chapters. He obtained his medical degree in Jaipur, India and completed his Residency and Fellowship training at Georgetown University Hospital and the University of Pennsylvania.

Tony Wondka
Vice President, Research and Development

Tony Wondka has held management and executive positions in the medical device industry for over 20 years, in large and small companies.  Prior to Capnia, he helped start Breathe Technologies, a JJDC- and KPCB-backed company partly based on his invention of a new form of ventilation therapy for treating COPD.  As VP of R&D then Clinical Affairs, he helped the company through Series C funding and helped prepare the NIOV™ product for commercialization.  Prior to Breathe, Tony was Director of R&D and VP of Manufacturing at Pulmonx where he co-invented and established successful first in human results of the Chartis™ diagnostic system and procedure.  Prior to his start up experience, Tony worked at Pfizer subsidiary Shiley (now Covidien), and Bear Medical (now Carefusion) where he held lead roles in engineering and quality assurance, supporting market leading respiratory and ENT products including a $100M/year product line.  He holds over 40 issued or pending patents and has a B.S. in Bioengineering from University of California San Diego.

Julie A. Blacklock
Director, Quality & Regulatory Affairs

Julie Blacklock joined Capnia in 2010. Prior to joining Capnia, she held management positions in quality and regulatory at diaDexus, Quidel Corporation, and Metra BioSystems, where she established the quality management systems leading to ISO 13485 certifications, developed and executed regulatory strategies, and prepared successful product submissions for U.S., Europe, and numerous other countries. She served as the quality and regulatory representative on the design, development, and commercialization teams of medical devices for infectious disease, reproductive health, bone health, cardiovascular disease, allergy, and hematology.

Julie Blacklock earned a B.A. in English from San Jose State University and holds the Regulatory Affairs Certification (RAC) from Regulatory Affairs Professionals Society.

Kristen Yen
Director, Clinical Operations

Kristen Yen has over 15 years of clinical research experience in the pharmaceutical industry. She joined Capnia in 2006 and currently heads Clinical Operations providing management and logistical oversight for all clinical programs. Prior to joining Capnia, she managed multiple U.S. and global clinical studies in oncology for six (6) years and held various positions of increasing responsibility at Titan Pharmaceuticals. She began her career in the industry as a clinical employee at PRA International. She has served as a team member or managed clinical studies in neonatology, neurology, pulmonary/allergy, cardiovascular disease, endocrine/metabolic disease and oncology.

Kristen earned a B.S. in Mathematics from University of California Davis and a M.S. in Cell, Molecular and Neurosciences from University of Hawaii Manoa.

Terms Of Use  |  Privacy Statement  |  Login